1. Abe F, Shibuya K, Uchida M, Takahashi K, Horinishi H, Matsuda A, Ishizuka M, Takeuchi T, Umezawa H (1984) Effect of bestatin on syngeneic tumors in mice. Gann 75: 89–94
2. Abe F, Shibuya K, Ashizawa J, Takahashi K, Horinishi H, Matsuda A, Ishizuka M, Takeuchi T, Umezawa H (1985) Enhancement of antitumor effect of cytotoxic agents by bestatin. J Antibiot (Tokyo) 38: 411–414
3. Abe F, Hayashi M, Horinishi H, Matsuda A, Ishizuka M, Umezawa H (1986) Enhancement of graft-versus-host reaction and delayed cutaneous hypersensitivity in mice by ubenimex. J Antibiot (Tokyo) 39: 1172–1177
4. Abe F, Alvord G, Koyama M, Matsuda A, Talmadge JE (1989) Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases. Cancer Immunol Immunother 28: 29–33
5. Abe F, Schneider M, Black PL, Talmadge JE (1989) Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice. Cancer Immunol Immunother 29: 231–236